Chelsea Therapeutics (CHTP) – FDA
-
Chelsea Therapeutics (CHTP) Reports Publication of Statistically Significant NORTHERA Phase 3 Data
-
Chelsea Therapeutics (CHTP) Presents Significant Date from Two Pivotal NORTHERA Studies
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CHTP Stock Lookup